Answers are grounded in this paper and cite their sources.
Rationale & Objective Patients with kidney failure on maintenance hemodialysis (KF-HD) face heightened infection susceptibility. Despite the clinical burden of ventilator-associated pneumonia (VAP) in critically ill patients, the impact of kidney failure on VAP risk and outcomes is unknown. Study Design Retrospective cohort study. Setting & Participants 3,615,730 hospitalizations for mechanically ventilated adults (≥21 years) in the AHRQ National Inpatient Sample (NIS), 2016–2020. Hospitalizations with KF-HD (n=205,925, 5.7%) were compared to non-kidney failure hospitalizations (n=3,409,805). Exposure(s) Kidney failure on maintenance hemodialysis, identified by ICD-10 diagnosis and procedure codes. Outcome(s) VAP incidence, in-hospital mortality, and length of stay (LOS). Analytical Approach Survey-weighted logistic regression (VAP, mortality) and negative binomial regression (LOS), with progressive adjustment for demographics, comorbidities, and hospital characteristics. Temporal trends and COVID-19 era stratification were assessed. Results The study included 3,615,730 hospitalizations for mechanically ventilated patients, of whom 205,925 (5.7%) were for patients with KF-HD. VAP incidence was higher in hospitalizations with KF-HD than non- KF hospitalizations (2.85% vs 2.64%, adjusted OR 1.18, 95% CI 1.10-1.26). Among hospitalizations with VAP, those with KF-HD had significantly higher in-hospital mortality (31.91% vs 23.69%, adjusted OR 1.25, 95% CI 1.09-1.43) and longer LOS (36.97 vs 27.85 days, adjusted IRR 1.16, 95% CI 1.06-1.27) than non- KF controls. VAP rates increased for both groups from 2016–2020, with the highest rates in 2020, but the relative impact of COVID-19 did not differ significantly between groups. Limitations Administrative ICD-10 data subject to coding inaccuracies; inability to assess clinical VAP prevention compliance; NIS hospitalization-level design; inability to distinguish hemodialysis-specific from kidney failure-specific effects. Conclusions Hospitalizations for patients with KF-HD face significantly increased VAP risk (18% higher) and, when VAP occurs, experience 25% higher mortality and 16% longer hospital stays. These findings highlight the need for heightened awareness and targeted VAP prevention strategies. Prospective studies are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: